Skip to content
RecallWatchMedical Device Safety
Class IOngoingZ-2985-2026

Bard Access Systems, Inc. recalls DuoGlide Short-Term Straight Dialysis Catheter

Bard Access Systems, Inc.Salt Lake City, UT, United StatesReported Sep 23, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

this is a downstream recall of class I recall RES 98777

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

DuoGlide Short-Term Straight Dialysis Catheter1 code
  • 5625150
DuoGlide Short-Term Straight Dialysis Catheter1 code
  • 5625200
DuoGlide Short-Term Straight Dialysis Catheter1 code
  • 5625240
DuoGlide Short-Term Straight Dialysis Catheter1 code
  • 5625300
DuoGlide Short-Term Curved Extension Dialysis Catheter1 code
  • 5626120
DuoGlide Short-Term Curved Extension Dialysis Catheter1 code
  • 5626150
DuoGlide Short-Term Curved Extension Dialysis Catheter1 code
  • 5626200
DuoGlide Short-Term Curved Extension Dialysis Catheter1 code
  • 5626240
Niagara Dual-Lumen Short-Term Curved Extension Dialysis Catheter1 code
  • 5766200

Lot / code information

Lot #
(Expiration): 5625150/801741042096/ REKS1082(8/31/2026), REKS2493(10/31/2026), REKU1654(10/31/2026), REKV2899(1/31/2027), REKX0416(3/31/2027), REKY1371(4/30/2027) — +30 moreShow all
(Expiration): 5625150/801741042096/ REKS1082(8/31/2026), REKS2493(10/31/2026), REKU1654(10/31/2026), REKV2899(1/31/2027), REKX0416(3/31/2027), REKY1371(4/30/2027), REKZ0520(5/31/2027); 5625200/801741042102/ REKQ3365(8/31/2026), REKR0913(9/30/2026), REKR3442(9/30/2026), REKS3566(10/31/2026), REKT3039(11/30/2026), REKV0934(12/31/2026), REKW2112(1/31/2027), REKX1756(3/31/2027), REKY1379(4/30/2027), REKZ2330(5/31/2027), RELP1350(7/31/2027); 5625240/801741042119/ REKS1561(9/30/2026), REKU1624(12/31/2026), REKW1234(2/28/2027), REKY0255(4/30/2027), REKY2419(4/30/2027), RELP2149(7/31/2027); 5625300/801741042126/ REKQ1106(8/31/2026), REKS1554(10/31/2026), REKW1239(2/28/2027), REKY1363(4/30/2027), RELN2943(6/30/2027); 5626120/801741042133/ REKU1592(12/31/2026), REKW0662(2/28/2027), REKY2397(4/30/2027); 5626150/801741042140/ REKQ3359(8/31/2026), REKS3561(10/31/2026), REKW0658(2/28/2027), REKY1388(4/30/2027), RELP1359(7/31/2027); 5626200/801741042157/ REKW1244(2/28/2027), REKY0237(4/30/2027); 5626240/801741042164/ REKR2191(9/30/2026), REKU1680(12/31/2026), REKW1230(1/31/2027), REKY0250(4/30/2027); 5575150/ 5766200/801741045714/ REKT1903(11/30/2026)

What the firm is doing

On 8/10/2026, recall notices were mailed or emailed to customers and distributors who were asked to do the following: 1) Do not use the Sodium chloride ampules contained within the affected products. The sodium chloride ampule is the only impacted component within the tray and all remaining components can continue to be used. 2) Secure an alternative local Sodium chloride prior to entering the procedural environment. 3) Upon opening the tray, remove and destroy the ampules within a controlled and sterile environment to maintain the sterility of the remaining components within the tray. 4) If affected Sodium chloride ampule was previously used without issue, no additional treatment or clinical follow up is required. 5) If affected Sodium chloride ampule was previously used with issue, report the incident per institutional guidelines and take any necessary actions. Take the Following Actions: a) Circulate this notice to all those who need to be aware within your organization or to any organization where the potentially affected products have been transferred. b) Post this notice on all inventory storage locations and any location where the product may be used. c) Label all affected trays using the template provided to facilitate easy identification of products containing the affected ampules. The label can be printed using Avery template 5160. d) Apply the labels to the product without covering or obscuring any regulatory or traceability information. e) Apply to the top web of the tray by pressing firmly to ensure adhesion, but don't damage or compromise the sterile barrier. Distributors are asked to identify all customers within their distribution network that purchased any affected product and to provide a copy of the customer letter to all customers. Complete and return response form via email to BDRC8@bd.com Report complaints to firm via: Phone: 1-844-823-5433 or Email: productcomplaints@bd.com

DistributionShow details

US: FL, IL, OH, VA, MD, TX, WI, GA, TN, IN, SC, NC, MI, PA, OR, OK, AZ, MS, NJ, AL, CA, CO, MA, NV, ID, MO, LA, WA, KY, IA, NH, NY, KS, HI, NE, MN, MT, WY, AR, RI, WV, UT, PR, DE, CT, ME, DC, ND, NM, SD

Class IWhat this means

A reasonable probability that use of the product will cause serious adverse health consequences or death.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class I recalls

Class IOngoingZ-3153-2026

AVID Medical, Inc. recalls Haylard BASIC BIOPSY TRAY

Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.

  • General Surgery Tray
  • Nonconforming Material/Component
AVID Medical, Inc.VASep 23, 2026
Class IOngoingZ-3152-2026

AVID Medical, Inc. recalls Haylard CONTINUOUS NERVE BLOCK TRAY

Potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical.

  • Custom Anesthesia Tray
  • Nonconforming Material/Component
AVID Medical, Inc.VASep 23, 2026